Venture capital funding for companies in CAR-T programs 2011-2016

This statistic shows the venture capital funding for select companies involved in CAR-T programs between 2011 and 2016. Kite Pharma had a venture capital funding of 15 million U.S. dollars in March 2011.

Venture capital funding for select companies involved in CAR-T programs between 2011 and 2016 (in million U.S. dollars)*

Venture capital in million U.S. dollars
Kite Pharma (March 2011)15
Kite Pharma (March 2013)20
Kite Pharma (April 2014)20
Juno (April 2014)176
Juno (August 2014)143
Bellicum (August 2014)55
Autolus (January 2015)45
Poseida (December 2015)23
CARsgen (January 2016)30
Autolus (March 2016)57
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2017

Region

United States

Survey time period

2011 to 2016

Supplementary notes

* CAR-T = chimeric antigen receptor T-cell.
Includes only venture capital funding for companies involved in CAR-T program(s) at the time of investment.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Cell and gene therapy"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.